A detailed history of State Street Corp transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 31,266 shares of XTNT stock, worth $13,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,266
Previous 31,266 -0.0%
Holding current value
$13,757
Previous $19,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.63 - $1.03 $5,670 - $9,270
9,000 Added 40.42%
31,266 $19,000
Q1 2024

May 15, 2024

SELL
$0.92 - $1.28 $9,752 - $13,568
-10,600 Reduced 32.25%
22,266 $26,000
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.35 $7,176 - $12,420
9,200 Added 38.87%
32,866 $36,000
Q1 2022

May 16, 2022

BUY
$0.57 - $0.88 $493 - $762
866 Added 3.8%
23,666 $16,000
Q2 2021

Aug 16, 2021

BUY
$1.38 - $2.46 $31,463 - $56,088
22,800 New
22,800 $37,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $47.6M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.